SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,586,102,000 | -94.4% | 14,965 | -96.3% | 0.01% | -95.7% |
| Q4 2014 | $45,901,634,000 | +305.3% | 399,353 | +451.0% | 0.16% | +1530.0% |
| Q3 2014 | $11,324,429,000 | -35.9% | 72,481 | -49.4% | 0.01% | -41.2% |
| Q2 2014 | $17,680,248,000 | -13.2% | 143,334 | -22.6% | 0.02% | +6.2% |
| Q1 2014 | $20,379,300,000 | -98.3% | 185,266 | -97.8% | 0.02% | -96.4% |
| Q4 2013 | $1,214,162,400,000 | +10937.5% | 8,241,076 | +4910.4% | 0.44% | +5437.5% |
| Q3 2013 | $11,000,300,000 | -9.1% | 164,478 | -10.1% | 0.01% | -11.1% |
| Q2 2013 | $12,102,100,000 | – | 182,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|